Hoth Therapeutics Inc
HOTH
查看详细走势图
1.090USD
+0.020+1.87%
收盘 12/19, 16:00（美东）报价延迟15分钟
16.49M总市值
亏损市盈率 TTM
盘中分时
1分
30分
1小时
日k
周k
月k
日k
今天
+1.87%
5天
-6.84%
1月
+5.83%
6月
-9.92%
今年开始到现在
+45.70%
1年
+34.57%
查看详细走势图
TradingKey Hoth Therapeutics Inc股票评分
单位: USD 更新时间: 2025-10-27操作建议
当前估值低估，机构持股占比非常高，近一月多位分析师给出公司评级为买入。最高目标价max_target_price。目前股价在压力位和支撑位之间，可以做区间波段操作。
Hoth Therapeutics Inc评分
压力支撑
由于公司未披露，未能获取相关数据
多维评测
本期评分
上期评分
分析师目标
根据
1
位分析师
买入
评级
4.500
目标均价
+287.93%
涨幅空间
数据免责声明：分析师评级与目标价由LSEG提供，仅供参考，不应当作投资建议
Hoth Therapeutics Inc亮点
亮点风险
Hoth Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing new generation therapies for unmet medical needs. The Company is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT), and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The Company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004), and a treatment for obesity, and obesity-related diseases and conditions (HT-VA).
Hoth Therapeutics Inc新闻
即将为您带来更多新闻，敬请期待。。。
财务指标
每股收益
由于公司未披露，未能获取相关数据
营业总收入
由于公司未披露，未能获取相关数据
Hoth Therapeutics Inc简介
Hoth Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing new generation therapies for unmet medical needs. The Company is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT), and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The Company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004), and a treatment for obesity, and obesity-related diseases and conditions (HT-VA).
公司代码HOTH
公司Hoth Therapeutics Inc
CEOKnie (Robb)
网址https://hoththerapeutics.com/
常见问题
Hoth Therapeutics Inc(HOTH)的当前股价是多少？
Hoth Therapeutics Inc(HOTH)的当前股价是 1.090。
Hoth Therapeutics Inc的股票代码是什么？
Hoth Therapeutics Inc的股票代码是HOTH。
Hoth Therapeutics Inc股票的52周最高点是多少？
Hoth Therapeutics Inc股票的52周最高点是3.800。
Hoth Therapeutics Inc股票的52周最低点是多少？
Hoth Therapeutics Inc股票的52周最低点是0.655。
Hoth Therapeutics Inc的市值是多少？
Hoth Therapeutics Inc的市值是16.49M。
Hoth Therapeutics Inc的净利润是多少？
Hoth Therapeutics Inc的净利润为-8.19M。
现在Hoth Therapeutics Inc(HOTH)的股票是买入、持有还是卖出？
根据分析师评级，Hoth Therapeutics Inc(HOTH)的总体评级为买入，目标价格为4.500。
Hoth Therapeutics Inc(HOTH)股票的每股收益（EPS TTM）是多少
Hoth Therapeutics Inc(HOTH)股票的每股收益（EPS TTM）是-1.022。
相关品种
